These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8223835)

  • 21. Pharmacokinetics of pantoprazole in patients with end-stage renal failure.
    Kliem V; Bahlmann J; Hartmann M; Huber R; Lühmann R; Wurst W
    Nephrol Dial Transplant; 1998 May; 13(5):1189-93. PubMed ID: 9623552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal Maturation of Paracetamol (Acetaminophen) Glucuronidation, Sulfation, and Oxidation Based on a Parent-Metabolite Population Pharmacokinetic Model.
    Cook SF; Stockmann C; Samiee-Zafarghandy S; King AD; Deutsch N; Williams EF; Wilkins DG; Sherwin CM; van den Anker JN
    Clin Pharmacokinet; 2016 Nov; 55(11):1395-1411. PubMed ID: 27209292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paracetamol metabolism in Indian population.
    Pabba SK; Bolla S; Kandhagatla R; Chaluvadi MR; Krishna DR
    Arzneimittelforschung; 2002; 52(10):769-72. PubMed ID: 12442640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates.
    Allegaert K; Anderson BJ; Naulaers G; de Hoon J; Verbesselt R; Debeer A; Devlieger H; Tibboel D
    Eur J Clin Pharmacol; 2004 May; 60(3):191-7. PubMed ID: 15071761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-dose pharmacokinetics of paracetamol and its conjugates in Chinese non-insulin-dependent diabetic patients with renal impairment.
    Chan MT; Anderson PJ; Chan JC; Lau GS; Critchley JA
    Eur J Clin Pharmacol; 1997; 52(4):285-8. PubMed ID: 9248766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic basis for high paracetamol dosage without hepatic injury: a case study.
    Tredger JM; Thuluvath P; Williams R; Murray-Lyon IM
    Hum Exp Toxicol; 1995 Jan; 14(1):8-12. PubMed ID: 7748624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis.
    Parasrampuria DA; Marbury T; Matsushima N; Chen S; Wickremasingha PK; He L; Dishy V; Brown KS
    Thromb Haemost; 2015 Apr; 113(4):719-27. PubMed ID: 25566930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetics and metabolism of paracetamol and phenacetin.
    Prescott LF
    Br J Clin Pharmacol; 1980 Oct; 10 Suppl 2(Suppl 2):291S-298S. PubMed ID: 7002186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple dose kinetics of ofloxacin and ofloxacin metabolites in haemodialysis patients.
    Kampf D; Borner K; Pustelnik A
    Eur J Clin Pharmacol; 1992; 42(1):95-9. PubMed ID: 1541323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of water deprivation on the disposition of paracetamol.
    Zafar NU; Niazi S; Jung D
    J Pharm Pharmacol; 1987 Feb; 39(2):144-7. PubMed ID: 2882004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of polysaccharide peptide (PSP) on in vivo sulphation and glucuronidation of paracetamol in the rat.
    Yeung JH; Chiu LC; Ooi VE
    Eur J Drug Metab Pharmacokinet; 1995; 20(4):287-92. PubMed ID: 8983934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration.
    Fuster-Lluch O; Zapater-Hernández P; Gerónimo-Pardo M
    J Clin Pharmacol; 2017 Oct; 57(10):1345-1352. PubMed ID: 28419483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of malaria infection on paracetamol disposition in the rat.
    Mansor SM; Edwards G; Roberts PJ; Ward SA
    Biochem Pharmacol; 1991 Jun; 41(11):1707-11. PubMed ID: 2043159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery.
    Owens KH; Medlicott NJ; Zacharias M; Curran N; Chary S; Thompson-Fawcett M; Reith DM
    Ther Drug Monit; 2012 Dec; 34(6):713-21. PubMed ID: 23149443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Paracetamol clinical dosing routine leads to paracetamol underexposure in an adult severely ill sub-Saharan African hospital population: a drug concentration measurement study.
    Bos JC; Mistício MC; Nunguiane G; Mathôt RAA; van Hest RM; Prins JM
    BMC Res Notes; 2017 Dec; 10(1):671. PubMed ID: 29202789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of ofloxacin and adequacy of maintenance dose for patients on haemodialysis.
    Kampf D; Borner K; Pustelnik A
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():61-8. PubMed ID: 2286592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of haemodialysis on the pharmacokinetics of tenoxicam in patients with end-stage renal disease.
    al-Ghamdi MS; al-Mohanna FA; al-Mustafa ZH; al-Saeed IS
    Eur J Clin Pharmacol; 1992; 43(2):197-9. PubMed ID: 1425878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and ocular disposition of paracetamol and paracetamol glucuronide in rabbits with diabetes mellitus induced by alloxan.
    Bienert A; Kamińska A; Olszewski J; Gracz J; Grabowski T; Wolc A; Grześkowiak E
    Pharmacol Rep; 2012; 64(2):421-7. PubMed ID: 22661194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paracetamol metabolism in chronic liver disease.
    Forrest JA; Adriaenssens P; Finlayson ND; Prescott LF
    Eur J Clin Pharmacol; 1979 Jul; 15(6):427-31. PubMed ID: 499292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paracetamol test: modification by renal function, urine flow and pH.
    Kietzmann D; Bock KW; Krähmer B; Kettler D; Bircher J
    Eur J Clin Pharmacol; 1990; 39(3):245-51. PubMed ID: 2257860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.